“GLP-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THERAPEUTIC POTENTIAL AND CLINICAL CHALLENGES”, IJITSS, vol. 1, no. 3(47), Jul. 2025, doi: 10.31435/ijitss.3(47).2025.3493.